Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Dose-Response in Healthy Volunteers
NCT02767089Phase 1Completed
- Sponsor
- Pfizer
- Start
- Oct 2005
- Primary completion
- Mar 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of prednisone in inflammation, sponsored by Pfizer. Primary endpoints: Osteocalcin at 8 days, Cortisol Suppression at 8 days and 9 more. Started Oct 2005; status: completed.
02
Drugs
prednisone
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT02767089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767089.